NEVVI Medicare utilization intelligence

← back

TRAN, PHUM.D. NPI 1891089587 Clinician

Hematology-Oncology · PORT ST LUCIE, FL

Specialty Hematology-Oncology — from billed Medicare claims
Trained CREIGHTON UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 15 years since medical school (class of 2011, self-reported to CMS)
Location PORT ST LUCIE, FL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 71 codes billed · 173,267 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
HEM ONC ASSOCIATES OF THE TREASURE COAST, PA
2021–2026
GENESIS MEDICAL GROUP, LLC
2019–2020

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-05

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9271 Injection, pembrolizumab, 1 mg
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
J0640 Injection, leucovorin calcium, per 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J9190 Injection, fluorouracil, 500 mg
82728 Ferritin (blood protein) level
80048 Blood test, basic group of blood chemicals (calcium, total)
96372 Injection of drug or substance under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83540 Iron level
83550 Iron binding capacity
96413 Administration of chemotherapy into vein, 1 hour or less
80053 Blood test, comprehensive group of blood chemicals
96375 Injection of additional new drug or substance into vein
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J2405 Injection, ondansetron hydrochloride, per 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
82607 Cyanocobalamin (vitamin b-12) level
J9045 Injection, carboplatin, 50 mg
83615 Lactate dehydrogenase (enzyme) level
96415 Administration of chemotherapy into vein, each additional hour
96361 Infusion into a vein for hydration, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
82746 Folic acid level, serum
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96360 Infusion into a vein for hydration, 31-60 minutes
J7030 Infusion, normal saline solution , 1000 cc
82378 Carcinoembryonic antigen (cea) protein level
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
80076 Liver function blood test panel
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
85610 Blood test, clotting time
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
84153 Psa (prostate specific antigen) measurement, total
96411 Administration of additional new drug or substance into vein using push technique
71260 Ct scan of chest with contrast
82565 Blood creatinine level
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
81000 Manual urinalysis test with examination using microscope, non-automated
74178 Ct scan of abdomen and pelvis before and after contrast
96523 Irrigation of implanted venous access drug delivery device
84520 Urea nitrogen level to assess kidney function, quantitative
83735 Magnesium level
93793 Anticoagulant management of patient taking warfarin
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg
71250 Ct scan of chest without contrast
74176 Ct scan of abdomen and pelvis without contrast
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
99195 Drawing of blood for a medical problem
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
36591 Collection of blood sample from implanted device
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82272 Stool analysis for blood, by peroxidase activity

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.